hsa-miR-4516 Mediated Downregulation of STAT3/CDK6/UBE2N Plays a Role in PUVA Induced Apoptosis in Keratinocytes

Journal of Cellular Physiology

Volumn 229, Issue 11, 2014, Pages 1630-1638

  Chowdhari, Shruti ^a   Saini, Neeru ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 6; HSA MICRORNA 4516; METHOXSALEN; MICRORNA; STAT3 PROTEIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME E 2 N PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CELL VIABILITY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; LUCIFERASE ASSAY; MTT ASSAY; PRIORITY JOURNAL; PROTEIN TARGETING; PSORIASIS; PUVA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ULTRAVIOLET A RADIATION; UPREGULATION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; APOPTOSIS; BASE SEQUENCE; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 6; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; KERATINOCYTES; METHOXSALEN; MICRORNAS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING; PSORIASIS; PUVA THERAPY; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; UBIQUITIN-CONJUGATING ENZYMES; ULTRAVIOLET RAYS;

EID: 84904891554     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24608     Document Type: Article

References (41)

1. Almutawa F, Alnomair N, Wang Y, Hamzavi I, Lim HW. 2013. Systematic review of UV-based therapy for psoriasis. Am J Clin Dermatol 14:87-109.
2. Aoki Y, Feldman GM, Tosato G. 2003. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101:1535-1542.
3. Bandyopadhyay S, Mitra R. 2009. TargetMiner: microRNA target prediction with systematic identification of tissue-specific negative examples. Bioinformatics 25:2625-2631.
4. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
5. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136:215-233.
6. Berneburg M, Herzinger T, Rampf J, Hoetzenecker W, Guenova E, Meisner C, Maetzke J, Schaefer T, Eberlein B, Scharffetter-Kochanek K, Rocken M. 2013. Efficacy of bath PUVA versus system PUVA in psoriasis: A prospective, open randomised multicentre study. Br J Dermatol. 169:704-708
7. Bernstein EF, Gasparro FP, Brown DB, Takeuchi T, Kong SK, Uitto J. 1996. 8-methoxypsoralen and ultraviolet a radiation activate the human elastin promoter in transgenic mice: In vivo and in vitro evidence for gene induction. Photochem Photobiol 64:369-374.
8. Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O'Toole M, Young DA, Fouser LA, Nickerson-Nutter C, Collins M, Dunussi-Joannopoulos K, Medley QG. 2011. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: Implications in psoriasis pathogenesis. J Invest Dermatol 131:2428-2437.
9. Dauer DJ, Ferraro B, Song L, Yu B, Mora L, Buettner R, Enkemann S, Jove R, Haura EB. 2005. Stat3 regulates genes common to both wound healing and cancer. Oncogene 24:3397-3408.
10. Dogra S, Yadav S. 2010. Psoriasis in India: Prevalence and pattern. Indian J Dermatol Venereol Leprol 76:595-601.
11. Gu X, Nylander E, Coates PJ, Nylander K. 2011. Effect of narrow-band ultraviolet B phototherapy on p63 and microRNA (miR-21 and miR-125b) expression in psoriatic epidermis. Acta Derm Venereol 91:392-397.
12. Huang C Y, Lin S, Tai WT, Hsieh CY, Shiau CW, Cheng AL, Chen KF. 2013. Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3. Int J Radiat Oncol Biol Phys 86:456-462.
13. Johnson R, Staiano-Coico L, Austin L, Cardinale I, Nabeya-Tsukifuji R, Krueger JG. 1996. PUVA treatment selectively induces a cell cycle block and subsequent apoptosis in human T-lymphocytes. Photochem Photobiol 63:566-571.
14. Joyce CE, Zhou X, Xia J, Ryan C, Thrash B, Menter A, Zhang W, Bowcock AM. 2011. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet 20:4025-4040.
15. Kastelan M, Prpic-Massari L, Brajac I. 2009. Apoptosis in psoriasis. Acta Dermatovenerol Croat 17:182-186.
16. Konnikova L, Kotecki M, Kruger MM, Cochran BH. 2003. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 3:23.
17. Krueger JG, Bowcock A. 2005. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis 64:ii30-ii36.
18. Leslie K, Lang C, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J. 2006. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res 66:2544-2552.
19. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. 2003. Prediction of mammalian microRNA targets. Cell 115:787-798.
20. Lin L, Deangelis S, Foust E, Fuchs J, Li C, Li PK, Schwartz EB, Lesinski GB, Benson D, Lu J, Hoyt D, Lin J. 2010. A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells. Mol Cancer 9:217.
21. Liu S, Wang Y. 2013. A quantitative mass spectrometry-based approach for assessing the repair of 8-methoxypsoralen-induced DNA interstrand cross-links and monoadducts in Mammalian cells. Anal Chem 85:6732-6739.
22. Lowes MA, Bowcock AM, Krueger JG. 2007. Pathogenesis and therapy of psoriasis. Nature 445:866-873.
23. Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, Russell CB. 2013. The emerging role of IL-17 in the pathogenesis of psoriasis: Preclinical and clinical findings. J Invest Dermatol 133:17-26.
24. Meyerson M, Harlow E. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 14:2077-2086.
25. Miyoshi K, Takaishi M, Nakajima K, Ikeda M, Kanda T, Tarutani M, Iiyama T, Asao N, DiGiovanni J, Sano S. 2011. Stat3 as a therapeutic target for the treatment of psoriasis: A clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol 131:108-117.
26. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. 2013. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Invest Dermatol 133:377-385.
27. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
28. Raj D, Brash DE, Grossman D. 2006. Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol 126:243-257.
29. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, Smyth GK. 2007. A comparison of background correction methods for two-colour microarrays. Bioinformatics 23:2700-2707.
30. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, Itami S, Nickoloff BJ, DiGiovanni J. 2005. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43-49.
31. Schneider LA, Hinrichs R, Scharffetter-Kochanek K. 2008. Phototherapy and photochemotherapy. Clin Dermatol 26:464-476.
32. Shen Y, Devgan G, Darnell JE, Jr., Bromberg JF. 2001. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci U S A 98:1543-1548.
33. Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, Tengvall-Linder M, Norstedt G, Alenius H, Homey B, Scheynius A, Stahle M, Pivarcsi A. 2007. MicroRNAs: Novel regulators involved in the pathogenesis of psoriasis?. PLoS ONE 2:e610.
34. Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB. 1979. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 300:809-813.
35. Tang F, Hajkova P, Barton SC, Lao K, Surani MA. 2006. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 34:e9.
36. Teng TS, Lin B, Manser E, Ng DC, Cao X. 2009. Stat3 promotes directional cell migration by regulating Rac1 activity via its activator betaPIX. J Cell Sci 122:4150-4159.
37. Tierney BJ, McCann GA, Cohn DE, Eisenhauer E, Sudhakar M, Kuppusamy P, Hideg K, Selvendiran K. 2012. HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells. Cancer Biol Ther 13:766-775.
38. Viola G, Fortunato E, Cecconet L, Del Giudice L, Dall'Acqua F, Basso G. 2008. Central role of mitochondria and p53 in PUVA-induced apoptosis in human keratinocytes cell line NCTC-2544. Toxicol Appl Pharmacol 227:84-96.
39. Wang X. 2008. MiRDB: A microRNA target prediction and functional annotation database with a wiki interface. RNA 14:1012-1017.
40. Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, Wei JW, Zhou HJ, Ren N, Ye QH, Dong QZ, Qin LX. 2013. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology 58:158-170.
41. Zhang X, Sun Y, Pireddu R, Yang H, Urlam MK, Lawrence HR, Guida WC, Lawrence NJ, Sebti SM. 2013. A novel inhibitor of STAT3 homodimerization selectively suppresses STAT3 activity and malignant transformation. Cancer Res 73:1922-1933.